The aforementioned findings suggest that in the alternative pathway, ACE2 inhibits the activation of the RAS and thus inhibits the JAK2/STAT3 pathway, reducing the inflammatory response and renal injury of DKD. The gene discussed is STAT3; the disease is diabetic kidney disease.